Literature DB >> 6488136

Preoperative radiation therapy for locally advanced vulvar cancer.

N F Hacker, J S Berek, G J Juillard, L D Lagasse.   

Abstract

Eight patients with locally advanced vulvar cancer that would have necessitated pelvic exenteration to encompass the primary tumor were given preoperative radiation therapy in an attempt to shrink the primary tumor and allow more conservative surgery. From 4400 to 5400 rad of external radiation were delivered to the primary tumor, and one patient received an additional 2400 rad from intracavitary therapy. Satisfactory shrinkage of tumor occurred in seven of the eight patients (87.5%), thus allowing conservative surgical excision. In four patients (50%), there was no viable tumor in the surgical specimen. Moist desquamation of the vulva occurred in all patients and was of sufficient severity to require temporary cessation of radiation in four patients (50%). Five received groin radiation, and one (20%) subsequently developed bilateral hip fractures. No other major morbidity occurred. Five of the eight patients (62.5%) are alive without evidence of disease at intervals ranging from 15 months to 10 years. Preoperative radiation in this group obviated the need for pelvic exenteration, resulting in significantly less morbidity without compromising survival.

Entities:  

Mesh:

Year:  1984        PMID: 6488136     DOI: 10.1002/1097-0142(19841115)54:10<2056::aid-cncr2820541003>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Authors:  A Gaudineau; D Weitbruch; P Quetin; S Heymann; T Petit; P Volkmar; F Bodin; M Velten; J F Rodier
Journal:  Oncol Lett       Date:  2012-07-27       Impact factor: 2.967

Review 2.  Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging.

Authors:  Mayur Virarkar; Sai Swarupa Vulasala; Taher Daoud; Sanaz Javadi; Chandana Lall; Priya Bhosale
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

Review 3.  Carcinoma of the vulva: combined modality treatment.

Authors:  Gustavo S Montana
Journal:  Curr Treat Options Oncol       Date:  2004-04

Review 4.  Chemoradiation for advanced primary vulval cancer.

Authors:  T S Shylasree; Andrew Bryant; Robert Ej Howells
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

5.  Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study.

Authors:  Pankaj Deka; Debabrata Barmon; Sushrata Shribastava; Amal Chandra Kataki; J D Sharma; M Bhattacharyya
Journal:  J Midlife Health       Date:  2014-01

Review 6.  Vulvar cancer: epidemiology, clinical presentation, and management options.

Authors:  Ibrahim Alkatout; Melanie Schubert; Nele Garbrecht; Marion Tina Weigel; Walter Jonat; Christoph Mundhenke; Veronika Günther
Journal:  Int J Womens Health       Date:  2015-03-20

Review 7.  Management of Advanced Squamous Cell Carcinoma of the Vulva.

Authors:  Linda J Rogers
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

8.  Cancer of the vulva: 2021 update.

Authors:  Alexander B Olawaiye; Mauricio A Cuello; Linda J Rogers
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.